Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bastert

Showing results (251-260 of 291) with videos related to

Pageof 30
Sort By:
Breast Cancer Research and Treatment|August 8, 1998
Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancerE F Solomayer, I J Diel, G C Meyberg, et al.
Archiv Fur Gynakologie|July 29, 1977
[In-vivo testing of human breast cancer with steroid hormones after transplantation to athymic nude mice (proceedings)]R T Michel, H Schmidt-Matthiesen, G Bastert, et al.
Archiv Fur Gynakologie|July 29, 1977
[Serum estradiol levels and the capacity of cytoplasmic estradiol receptors in the breast tissue of lactating rate as detected by gel electrophoresis (proceedings)]R T Michel, H Schmidt-Matthiesen, H P Fortmeyer, et al.
Bone Marrow Transplantation|October 9, 2002
Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantationG Egerer, H Goldschmidt, M Hensel, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1992
[Palliative laser therapy in gynecologic oncology]D Wallwiener, S Rimbach, M Kaufmann, et al.
Zentralblatt Fur Gynakologie|January 1, 1994
[Surgical hysteroscopy: complications, safety aspects, education and training]D Wallwiener, S Rimbach, B Aydeniz, et al.
Cancer Gene Therapy|June 8, 1999
Interleukin-12 requires initial CD80-mediated T-cell activation to support immune responses toward human breast and ovarian carcinomaB Gückel, G C Meyer, W Rudy, et al.
International Journal of Cancer|April 3, 2001
Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patientsM Feuerer, M Rocha, L Bai, et al.
Cancer Chemotherapy and Pharmacology|December 22, 1999
Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancerS Hohaus, S Martin, A Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde|October 1, 1994
[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]H P Sinn, H Schmid, H Junkermann, et al.
Pageof 30

Showing results (251-260 of 291) with videos related to

Sort By:
Pageof 30
Breast Cancer Research and Treatment|August 8, 1998
Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancerE F Solomayer, I J Diel, G C Meyberg, et al.
Archiv Fur Gynakologie|July 29, 1977
[In-vivo testing of human breast cancer with steroid hormones after transplantation to athymic nude mice (proceedings)]R T Michel, H Schmidt-Matthiesen, G Bastert, et al.
Archiv Fur Gynakologie|July 29, 1977
[Serum estradiol levels and the capacity of cytoplasmic estradiol receptors in the breast tissue of lactating rate as detected by gel electrophoresis (proceedings)]R T Michel, H Schmidt-Matthiesen, H P Fortmeyer, et al.
Bone Marrow Transplantation|October 9, 2002
Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantationG Egerer, H Goldschmidt, M Hensel, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1992
[Palliative laser therapy in gynecologic oncology]D Wallwiener, S Rimbach, M Kaufmann, et al.
Zentralblatt Fur Gynakologie|January 1, 1994
[Surgical hysteroscopy: complications, safety aspects, education and training]D Wallwiener, S Rimbach, B Aydeniz, et al.
Cancer Gene Therapy|June 8, 1999
Interleukin-12 requires initial CD80-mediated T-cell activation to support immune responses toward human breast and ovarian carcinomaB Gückel, G C Meyer, W Rudy, et al.
International Journal of Cancer|April 3, 2001
Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patientsM Feuerer, M Rocha, L Bai, et al.
Cancer Chemotherapy and Pharmacology|December 22, 1999
Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancerS Hohaus, S Martin, A Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde|October 1, 1994
[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]H P Sinn, H Schmid, H Junkermann, et al.
Pageof 30